Our Product
Menu
Previous
Next
About us
Chemie Pharmed Pars Company was established in 2017 with the investment of the private sector and after the necessary studies and creating employment opportunities for young Iranian scientists and in the year named “Leap of Production”, it was purchased and owned. Obtaining manufacturing, production, sales, agreement in principle, as well as the facilities of Novin Kavosh Mamtir Company (Nokam) in Kaveh Industrial City, Saveh, which has been without economic activity for about 3 years and most of the received licenses have expired and the equipment is worn out. Unused, in relation to the revitalization of production facilities and reconstruction of production lines, as well as the re-receipt of the necessary licenses from the Food and Drug Administration, has injected a new economic life into the complex under the name of Pharmed Pars Chemistry and has provided employment for 40 people.
Latest News
Industry News
Holding Pharmex 2020 exhibition
Holding Pharmex 2020 exhibition
The second period of Pharmex 2020 exhibition was held in July of this year with a break of about 4 months with the presence of the largest active pharmaceutical companies and related activists in the field at the Olympic Hotel in Tehran. During the 3 days of holding the most important exhibition of the pharmaceutical raw materials industry, the relevant officials in this field, while visiting the booths of companies active in this field, talked to the CEOs and colleagues of the raw materials industry.
Company News
Lactose production by the company's research unit
Production of the first batch of the product
Board members visit production lines
Lactose production by the company's research unit
With the efforts of researchers and specialists in the field of raw material synthesis, the colleagues of the research and development unit of Pars Chemical Company succeeded in producing lactose for consumption by pharmaceutical companies. This research process is important because about 5,000 tons of lactose is imported annually by pharmaceutical companies from foreign sources and is used in the production process, which is the main source of currencies allocated to pharmaceutical companies. It is worth noting that with the reduction of the second wave of the Corona virus outbreak, the official unveiling of this important achievement will be announced in the coming days.
Production of the first batch of the product
At the height of the coronavirus outbreak and in order to prevent drug shortages with many follow-ups and full-time presence of the company’s staff, the first batch of calcium’s active ingredients, atorvastatin, has been produced with higher quality than pharmacopoeial standards. In the production process of this product, the highest quality sources of intermediates and stimulants of atorvastatin have been used.
Board members visit production lines
On Tuesday, 2020/07/14, the members of the company’s board of directors, while attending the company and visiting the production lines and talking to the hardworking personnel, appreciated and thanked them for their efforts in recent months. During this visit, Mr. Massoud Dadgarpour, referring to the outbreak of the Corona virus, stressed the need for more personal observance and asked God Almighty for blessings.
